Edition
ISBN:
1617371106 /
ISBN-13:
9781617371103
Book Details
Seller
Sort
Seller Rating
Price: Low to High
Price: High to Low
Condition
Condition: Reverse
Pub Date
Pub Date: Reverse
Sellers Near Me
Paperback,
New
Brain Tumor Immunotherapy
by Liau, Linda M. (Editor), and Becker, Donald P. (Editor), and Cloughesy, Timothy F. (Editor)
2010, Humana Press Inc.
ISBN-13:
9781617371103
See Item Details ▾
Alibris
BEST
NV, USA
$159.69
$219.99
Add to Cart
Add this copy of Brain Tumor Immunotherapy to cart. $159.69, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2010 by Humana Press Inc..
Edition: 2010, Humana Press Inc.
Paperback,
New
Available Copies: 10+
Details: ISBN:
1617371106
ISBN-13:
9781617371103
Publisher:
Humana Press Inc.
Published:
2010
Language:
English
Alibris ID:
10537209926
Shipping Options: Standard Shipping: $4.99
Trackable Expedited: $9.99
Two Day Air: $29.99
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description: New. Print on demand XII, 374 p. Intended for professional and scholarly audience.
Hide Details ▴
Paperback,
New
Brain Tumor Immunotherapy
by Liau, Linda M. (Editor), and Becker, Donald P. (Editor), and Cloughesy, Timothy F. (Editor)
2010, Humana Press Inc.
ISBN-13:
9781617371103
See Item Details ▾
Ria Christie Books
BEST
Uxbridge,
MIDDLESEX,
UNITED KINGDOM
$198.05
$219.99
Add to Cart
Add this copy of Brain Tumor Immunotherapy to cart. $198.05, new condition, Sold by Ria Christie Books rated 5.0 out of 5 stars, ships from Uxbridge, MIDDLESEX, UNITED KINGDOM, published 2010 by Humana Press Inc..
Edition: 2010, Humana Press Inc.
Paperback,
New
Available Copies: 10+
Details: ISBN:
1617371106
ISBN-13:
9781617371103
Publisher:
Humana Press Inc.
Published:
2010
Language:
English
Alibris ID:
18969825387
Shipping Options: Standard Shipping: $4.99
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description: New. Contains: Unspecified. Includes unspecified. Intended for professional and scholarly audience.
Hide Details ▴
